Go to
JCI Insight
Citations to this article
Mårten C.G. Winge, … , Elizabeth A. Waterman, M. Peter Marinkovich
Published June 13, 2016
Citation Information: J Clin Invest. 2016;126(7):2661-2677. https://doi.org/10.1172/JCI85738.
Citation Information: J Clin Invest. 2016;126(7):2661-2677. https://doi.org/10.1172/JCI85738.
Abstract
Interactions between the epidermis and the immune system govern epidermal tissue homeostasis. These epidermis-immune interactions are altered in the inflammatory disease psoriasis; however, the pathways that underlie this aberrant immune response are not well understood. Here, we determined that Ras-related C3 botulinum toxin substrate 1 (RAC1) is a key mediator of epidermal dysfunction. RAC1 activation was consistently elevated in psoriatic epidermis and primary psoriatic human keratinocytes (PHKCs) exposed to psoriasis-related stimuli, but not in skin from patients with basal or squamous cell carcinoma. Expression of a constitutively active form of RAC1 (RACV12) in mice resulted in the development of lesions similar to those of human psoriasis that required the presence of an intact immune system. RAC1V12-expressing mice and human psoriatic skin showed similar RAC1-dependent signaling as well as transcriptional overlap of differentially expressed epidermal and immune pathways. Coculture of PHKCs with immunocytes resulted in the upregulation of RAC1-dependent proinflammatory cytokines, an effect that was reproduced by overexpressing RAC1 in normal human keratinocytes. In keratinocytes, modulating RAC1 activity altered differentiation, proliferation, and inflammatory pathways, including STAT3, NFκB, and zinc finger protein 750 (ZNF750). Finally, RAC1 inhibition in xenografts composed of human PHKCs and immunocytes abolished psoriasiform hyperplasia and inflammation in vivo. These studies implicate RAC1 as a potential therapeutic target for psoriasis and as a key orchestrator of pathologic epidermis-immune interactions.
Authors
Mårten C.G. Winge, Bungo Ohyama, Clara N. Dey, Lisa M. Boxer, Wei Li, Nazanin Ehsani-Chimeh, Allison K. Truong, Diane Wu, April W. Armstrong, Teruhiko Makino, Matthew Davidson, Daniela Starcevic, Andreas Kislat, Ngon T. Nguyen, Takashi Hashimoto, Bernard Homey, Paul A. Khavari, Maria Bradley, Elizabeth A. Waterman, M. Peter Marinkovich
Total citations by year
Citation information
Citations to this article (34)
| Title and authors | Publication | Year |
|---|---|---|
|
Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma
Guo Y, Chang G, Wan R, Zhang X, Ma Z, Bai H, Wang J |
Journal of Cancer | 2024 |
|
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS
Yin G, Huang J, Petela J, Jiang H, Zhang Y, Gong S, Wu J, Liu B, Shi J, Gao Y |
Signal Transduction and Targeted Therapy | 2023 |
|
The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
Roy T, Boateng ST, Uddin MB, Banang-Mbeumi S, Yadav RK, Bock CR, Folahan JT, Siwe-Noundou X, Walker AL, King JA, Buerger C, Huang S, Chamcheu JC |
Cells | 2023 |
|
Lnc-HULC, miR-122, and sirtulin-1 as potential diagnostic biomarkers for psoriasis and their association with the development of metabolic syndrome during the disease course.
Erfan R, Shaker OG, Khalil MAF, AlOrbani AM, Abu-El-Azayem AK, Samy A, Zaki OM, Abdelhamid H, Fares R, Mohammed A |
Non-coding RNA Research | 2023 |
|
Mind bomb 2 limits inflammatory dermatitis in Sharpin mutant mice independently of cell death.
Simpson DS, Anderton H, Yousef J, Vaibhav V, Cobbold SA, Bandala-Sanchez E, Kueh AJ, Dagley LF, Herold MJ, Silke J, Vince JE, Feltham R |
2023 | |
|
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy
J Weidhaas, N Marco, A Scheffler, A Kalbasi, K Wilenius, E Rietdorf, J Gill, M Heilig, C Desler, R Chin, T Kaprealian, S McCloskey, A Raldow, N Raja, S Kesari, J Carrillo, A Drakaki, M Scholz, D Telesca |
Journal for ImmunoTherapy of Cancer | 2022 |
|
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
X Zhou, Y Chen, L Cui, Y Shi, C Guo |
Cell Death and Disease | 2022 |
|
Transcriptional Analysis-Based Alterations Affecting Neuritogenesis of the Peripheral Nervous System in Psoriasis
D Romhányi, K Szabó, L Kemény, E Sebestyén, G Groma |
Life Sciences | 2022 |
|
The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling.
Ma X, Ma X, Zhu L, Zhao Y, Chen M, Li T, Lin Y, Ma D, Sun C, Han L |
Oncogenesis | 2022 |
|
Rac1, A Potential Target for Tumor Therapy
J Liang, L Oyang, S Rao, Y Han, X Luo, P Yi, J Lin, L Xia, J Hu, S Tan, L Tang, Q Pan, Y Tang, Y Zhou, Q Liao |
Frontiers in Oncology | 2021 |
|
Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes
B Ehst, Z Wang, J Leitenberger, D McClanahan, RD Torre, E Sawka, AG Ortega-Loayza, J Strunck, T Greiling, E Simpson, Y Liu |
Cytokine | 2021 |
|
Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression
A Pecora, J Laprise, M Dahmene, M Laurin |
Cancers | 2021 |
|
Dysregulation of lncRNAs in autoimmune neuropathies
M Gholipour, M Taheri, JM Habibabadi, N Nazer, A Sayad, S Ghafouri-Fard |
Scientific Reports | 2021 |
|
Characterization of PCSK9 in the Blood and Skin of Psoriasis
MS Garshick, Y Baumer, AK Dey, R Grattan, Q Ng, HL Teague, ZX Yu, MY Chen, M Tawil, TJ Barrett, J Underberg, EA Fisher, J Krueger, TM Powell-Wiley, MP Playford, JS Berger, NN Mehta |
Journal of Investigative Dermatology | 2021 |
|
A computational multi-targeting approach for drug repositioning for psoriasis treatment
A Ibezim, E Onah, EN Dim, F Ntie-Kang |
2021 | |
|
Mouse Models of Psoriasis – A Comprehensive Review
Gangwar RS, Gudjonsson JE, Ward NL |
Journal of Investigative Dermatology | 2021 |
|
KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease
Allison C. Billi, Jessica E. Ludwig, Yi Fritz, Richard Rozic, William R. Swindell, Lam C. Tsoi, Dennis Gruszka, Shahla Abdollahi-Roodsaz, Xianying Xing, Doina Diaconu, Ranjitha Uppala, Maya I. Camhi, Philip A. Klenotic, Mrinal K. Sarkar, M. Elaine Husni, Jose U. Scher, Christine McDonald, J. Michelle Kahlenberg, Ronald J. Midura, Johann E. Gudjonsson, Nicole L. Ward |
Journal of Clinical Investigation | 2020 |
|
Activation of STAT transcription factors by the Rho-family GTPases
J Corry, HR Mott, D Owen |
Biochemical Society Transactions | 2020 |
|
Evaluation of active Rac1 levels in cancer cells: A case of misleading conclusions from immunofluorescence analysis
MJ Baker, M Cooke, G Kreider-Letterman, R Garcia-Mata, PA Janmey, MG Kazanietz |
The Journal of biological chemistry | 2020 |
|
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
S Rahmati, DD ORielly, Q Li, D Codner, A Dohey, K Jenkins, I Jurisica, DD Gladman, V Chandran, P Rahman |
Scientific Reports | 2020 |
|
Hyperlipidaemia and IFNgamma/TNFalpha Synergism are associated with cholesterol crystal formation in Endothelial cells partly through modulation of Lysosomal pH and Cholesterol homeostasis
Y Baumer, AK Dey, CA Gutierrez-Huerta, NO Khalil, Y Sekine, GE Sanda, J Zhuang, A Saxena, E Stempinski, YA Elnabawi, PK Dagur, Q Ng, HL Teague, A Keel, JA Rodante, WA Boisvert, LC Tsoi, JE Gudjonsson, CK Bleck, MY Chen, DA Bluemke, JM Gelfand, DM Schwartz, HS Kruth, TM Powell-Wiley, MP Playford, NN Mehta |
EBioMedicine | 2020 |
|
Keratinocytes Derived from Patient-Specific Induced Pluripotent Stem Cells Recapitulate the Genetic Signature of Psoriasis Disease
G Ali, AK Elsayed, M Nandakumar, M Bashir, I Younis, YA Aqel, B Memon, R Temanni, F Abubaker, S Taheri, EM Abdelalim |
Stem Cells and Development | 2020 |
|
Loss of the Epigenetic Mark 5-hmC in Psoriasis: Implications for Epidermal Stem Cell Dysregulation
F Li, CW Yuan, S Xu, T Zu, Y Woappi, CA Lee, P Abarzua, M Wells, MR Ramsey, NY Frank, X Wu, A Mandinova, MH Frank, CG Lian, GF Murphy |
Journal of Investigative Dermatology | 2020 |
|
Coordination between Rac1 and Rab Proteins: Functional Implications in Health and Disease
Margiotta, Bucci |
Cells | 2019 |
|
Psoriasis: Past, Present, and Future
AC Billi, JE Gudjonsson, JJ Voorhees |
Journal of Investigative Dermatology | 2019 |
|
An RNAi screen unravels the complexities of Rho GTPase networks in skin morphogenesis
M Laurin, NC Gomez, J Levorse, A Sendoel, M Sribour, E Fuchs |
eLife | 2019 |
|
Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis
Yvonne Baumer, Qimin Ng, Gregory Sanda, Amit Dey, Heather Teague, Alexander Sorokin, Pradeep Dagur, Silverman Joanna, Charlotte Harrington, Justin Rodante, Shawn Rose, Nevin Varghese, Agastya Belur, Aditya Goyal, Joel M. Gelfand, Danielle Springer, Christopher Bleck, Crystal Thomas, Zu Xi Yu, Mårten CG Winge, Howard Kruth, Peter Marinkovich, Aditya Joshi, Martin Playford, Nehal Mehta |
JCI Insight | 2018 |
|
Topical Application of Tat-Rac1 Promotes Cutaneous Wound Healing in Normal and Diabetic Mice
B Fan, T Wang, L Bian, Z Jian, DD Wang, F Li, F Wu, T Bai, G Zhang, N Muller, B Holwerda, G Han, XJ Wang |
International journal of biological sciences | 2018 |
|
Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway
J Jia, C Li, J Yang, X Wang, R Li, S Luo, Z Li, J Liu, Z Liu, Y Zheng |
Scientific Reports | 2018 |
|
IAPs protect host target tissues from graft-versus-host disease in mice
T Toubai, C Rossi, K Oravecz-Wilson, C Liu, C Zajac, SR Wu, Y Sun, H Fujiwara, H Tamaki, D Peltier, M Riwes, I Henig, S Brabbs, CS Duckett, S Wang, P Reddy |
Blood Advances | 2017 |
|
Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis
MC Winge, MP Marinkovich |
Small GTPases | 2017 |
|
An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies
S Singh, P Young, AW Armstrong, S Taheri |
PloS one | 2017 |
|
RNA-seq identifies a diminished differentiation gene signature in primary monolayer keratinocytes grown from lesional and uninvolved psoriatic skin
WR Swindell, MK Sarkar, Y Liang, X Xing, J Baliwag, JT Elder, A Johnston, NL Ward, JE Gudjonsson |
Scientific Reports | 2017 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)